BioSig Technologies appoints Anthony Amato as CEO

BioSig Technologies announced the appointment of Anthony Amato to the position of Chief Executive Officer, effective immediately. Additionally, Amato will serve on the company’s board of directors, which is currently being assembled. “Recall, that on April 4, 2024, the company announced the engagement of Consulting firm, Bridge Associates International Pharmaceutical Consulting, led by Mr. Amato. This corporate action was the natural progression as the company continues to realize meaningful progress towards its goals of both resorting and creating lasting shareholder value,” BioSig stated.